Azome Therapeutics Email Formats

Biotechnology Research • United States • 1-10 Employees

Key Contact at Azome Therapeutics

Rashmin Savani

Co-Founder and Head, Scientific Advisory Board

Company overview

Headquarters	United States
Website	azometherapeutics.com
NAICS	541714
Founded	2023
Employees	1-10
Socials

About Azome Therapeutics

Azome Therapeutics is an early-stage drug discovery company focused on developing selective antagonists of the NLRP3 inflammasome, an inflammatory pathway critical to the development of a wide variety of diseases. Our lead candidate, AZM-152, is a RHAMM-derived antagonist that blocks a key upstream priming signal involved in the aberrant activation of the NLRP3 inflammatory cascade.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Funding Data

Explore Azome Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-03-06	3	N/A

Funding Insights

Number of funding rounds

Azome Therapeutics Tech Stack

Discover the technologies and tools that power Azome Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

WordPress.com

PaaS

GoDaddy

Hosting

Wix

Blogs

HTTP/3

Miscellaneous

PHP

Programming languages

Open Graph

Miscellaneous

HSTS

Security

React

JavaScript frameworks

WordPress

Blogs

Frequently asked questions

Azome Therapeutics is located in US.

Azome Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Azome Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Azome Therapeutics

Rashmin Savani

Co-Founder and Head, Scientific Advisory Board

4.8

40,000 users